51
|
Kim JE, Choi J, Park J, Lee JK, Kang D, Choi JY. Association of postmenopausal hormone replacement therapy on metabolic syndrome components among diabetic and nondiabetic women. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.05.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
52
|
Taverna D, Garrovillo S, Blouw B, Thompson B, Kang D. PO-263 Assessment of the accumulation of hyaluronan in the tumour microenvironment (TME) of solid tumours. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
53
|
Kang D, Choi C, Kim H, Park S, Kim S, Ryu D, Ko J, Lee J, Lee J, Lee K, Kwon B, Kim H, Nam H. Associated factors with overlooked multiple synchronous gastric epithelial neoplasia. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
54
|
Kim S, Choi C, Kang D, Kim H, Park S, Ryu D, Ko J, Kim H, Kwon B, Lee K, Lee J, Lee J, Nam H. Clinical outcomes of endoscopic submucosal dissection for lesions on the proximal location of the stomach. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
55
|
Kang D, Kim H, Choi C, Park S, Kim S, Nam H, Ryu D, Ko J, Kim H, Kwon B, Lee K, Lee J, Lee J. Long-term clinical outcomes in large colorectal polyps with indefinite or positive resection margin after endoscopic resection. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
56
|
Souratha J, Osgood R, Cowell J, Fathallah A, Thompson C, Printz M, Maneval D, Kang D. PO-298 Pegylated recombinant human hyaluronidase PH20 (PEGPH20) increases tumour uptake and efficacy of cetuximab in a human pancreatic cancer xenograft model. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.811] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
57
|
Thompson B, Lee J, Clift R, Taverna D, Garrovillo S, Blouw B, Kang D, Thompson C, Maneval D. PO-262 Remodelling of the tumour microenvironment by pegvorhyalurondiase alfa (PEGPH20): a novel, first-in-class biologic that enzymatically degrades tumour hyaluronan (HA) to improve anti-tumour efficacy. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.777] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
58
|
Kedzierski MA, Lin L, Kang D. Pool Boiling of Low-GWP Replacements for R134a on a Reentrant Cavity Surface. JOURNAL OF HEAT TRANSFER 2018; 140:10.1115/1.4040783. [PMID: 31274925 PMCID: PMC6605071 DOI: 10.1115/1.4040783] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
This paper quantifies the pool boiling performance of R134a, R1234yf, R513A, and R450A on a flattened, horizontal reentrant cavity surface. The study showed that the boiling performance of R134a on the Turbo-ESP exceeded that of the replacement refrigerants for heat fluxes greater than 20 kWm-2. On average, the heat flux for R1234yf and R513A was 16 % and 19 % less than that for R134a, respectively, for R134a heat fluxes between 20 kWm-2 and 110 kWm-2. The heat flux for R450A was on average 57 % less than that of R134a for heat fluxes between 30 kWm-2 and 110 kWm-2. A model was developed to predict both single-component and multi-component pool boiling of the test refrigerants on the Turbo-ESP surface. The model accounts for viscosity effects on bubble population and uses the Fritz (1935) equation to account for increased vapor production with increasing superheat. Both loss of available superheat and mass transfer resistance effects were modeled for the refrigerant mixtures. For most heat fluxes, the model predicted the measured superheat to within ± 0.31 K.
Collapse
|
59
|
Kedzierski M, Kang D. Horizontal convective boiling of R1234yf, R134a, and R450A within a micro-fin tube. REVUE INTERNATIONALE DU FROID 2018; 88:10.1016/j.ijrefrig.2018.02.021. [PMID: 30983648 PMCID: PMC6459623 DOI: 10.1016/j.ijrefrig.2018.02.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
This paper presents local convective boiling heat transfer and Fanning friction factor measurements in a micro-fin tube for R134a and two possible low global warming potential (GWP) refrigerant replacements for R134a, namely R1234yf and R450A. Test section heating was achieved with water in either counterflow or in parallel flow with the test refrigerant to provide for a range of heat fluxes for each thermodynamic quality. An existing correlation from the literature for single and multi-component mixtures was shown to not satisfactorily predict the convective boiling measurements for flow qualities greater than 40%. Accordingly, a new correlation was developed specifically for the test fluids of this study so that a fair comparison of the heat transfer performance of the low GWP refrigerants to that of R134a could be made. The new correlation was used to compare the heat transfer coefficient of the three test fluids at the same heat flux, saturated refrigerant temperature, and refrigerant mass flux. The resulting example comparison, for the same operating conditions, showed that the heat transfer coefficient of the multi-component R450A and the single-component R1234yf were, on average, 15% less and 5% less, respectively, than that of the single-component R134a. Friction factor measurements were also compared to predictions from an existing correlation. A new correlation for the friction factor was developed to provide a more accurate prediction. The measurements and the new models are important for the evaluation of potential low-GWP refrigerants replacements for R134a.
Collapse
|
60
|
Arteaga-Velázquez J, Rivera-Rangel D, Apel W, Bekk K, Bertaina M, Blümer J, Bozdog H, Brancus I, Cantoni E, Chiavassa A, Cossavella F, Daumiller K, Souza VD, Pierro FD, Doll P, Engel R, Fuhrmann D, Gherghel-Lascu A, Gils H, Glasstetter R, Grupen C, Haungs A, Heck D, Hörandel J, Huege T, Kampert K, Kang D, Klages H, Link K, Łuczak P, Mathes H, Mayer H, Milke J, Mitrica B, Morello C, Oehlschläger J, Ostapchenko S, Pierog T, Rebel H, Roth M, Schieler H, Schoo S, Schröder F, Sima O, Toma G, Trinchero G, Ulrich H, Weindl A, Wochele J, Zabierowski J. Tests of the SIBYLL 2.3 high-energy hadronic interaction model using the KASCADE-Grande muon data. EPJ WEB OF CONFERENCES 2018. [DOI: 10.1051/epjconf/201817207003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The KASCADE-Grande observatory was a ground-based air shower array dedicated to study the energy and composition of cosmic rays in the energy interval E = 1 PeV –1 EeV. The experiment consisted of different detector systems which allowed the simultaneous measurement of distinct components of air showers (EAS), such as the muon content. In this contribution, we study the total muon number and the lateral density distribution of muons in EAS detected by KASCADE-Grande as a function of the zenith angle and the total number of charged particles. The attenuation length of the muon content of EAS is also measured. The results are compared with the predictions of the SIBYLL 2.3 high-energy hadronic interaction model.
Collapse
|
61
|
Kang D, Kim IR, Lee DY, Ahn J, Park JH, Guallar E, Cho J. Incidence of permanent chemotherapy-induced alopecia among breast cancer patients: A five-year prospective cohort study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx655.022] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
62
|
Cho J, Kang D, Park JH, Kim IR, Guallar E, Lee DY, Ahn J. Evaluation of the impact of a topical lotion, CG428, on permanent chemotherapy induced hair and scalp disorders in cancer survivors: a randomized controlled pilot trial (VOLUME). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx676.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
63
|
Trail Ross M, Kang D, Cron S. KINSHIP CAREGIVER STRESS, BURDEN, HEALTH, SOCIAL SUPPORT, AND NEEDS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.1650] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
64
|
Song X, Roy B, Kang D, Aysola RS, Macey P, Woo M, Harper R, Kumar R. 0142 DECREASED REGIONAL HOMOGENEITY IN THE DEFAULT MODE NETWORK IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
65
|
Tang W, Mao J, Liu C, Mollan K, Wong T, Zhang Y, Tang S, Hudgens M, Qin Y, Ma B, Liao M, Yang B, Ma W, Kang D, Wei C, Tucker J. Reimagining Health Communication: A Non-Inferiority Randomized Controlled
Trial of Crowdsourcing in China. Ann Glob Health 2017. [DOI: 10.1016/j.aogh.2017.03.371] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
66
|
Hong A, Lee HH, Heo CE, Cho Y, Kim S, Kang D, Kim HI. Distinct Fragmentation Pathways of Anticancer Drugs Induced by Charge-Carrying Cations in the Gas Phase. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 2017; 28:628-637. [PMID: 27981443 DOI: 10.1007/s13361-016-1559-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Revised: 10/24/2016] [Accepted: 10/31/2016] [Indexed: 06/06/2023]
Abstract
With the growth of the pharmaceutical industry, structural elucidation of drugs and derivatives using tandem mass spectrometry (MS2) has become essential for drug development and pharmacokinetics studies because of its high sensitivity and low sample requirement. Thus, research seeking to understand fundamental relationships between fragmentation patterns and precursor ion structures in the gas phase has gained attention. In this study, we investigate the fragmentation of the widely used anticancer drugs, doxorubicin (DOX), vinblastine (VBL), and vinorelbine (VRL), complexed by a singly charged proton or alkali metal ion (Li+, Na+, K+) in the gas phase. The drug-cation complexes exhibit distinct fragmentation patterns in tandem mass spectra as a function of cation size. The trends in fragmentation patterns are explicable in terms of structures derived from ion mobility mass spectrometry (IM-MS) and theoretical calculations. Graphical Abstract ᅟ.
Collapse
|
67
|
Kang D, Lee J. P09.19 Glioblastoma Multiforme in an adult after Complete Remission of Acute Lymphoblastic Lymphoma. Neuro Oncol 2017. [DOI: 10.1093/neuonc/nox036.275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
68
|
Kim JY, Cho J, Kim H, Kang D, Jung HA, Lee SH, Bae S, Yu JH, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH, Guallar E, Park YH. Abstract P6-09-50: Impact of young age on recurrence and mortality after surgery in breast cancer: 15 years active surveillance. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p6-09-50] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction:Substantial efforts have been made to find factors associated with breast cancer (BC) recurrence and mortality after BC treatment. So far TNM stage, ER, PR, and HER2 status are considered as the major predictive markers of BC recurrence and used for treatment decision. However, most of these factors were evaluated independent from other important confounders such as age, stage, and various anti-cancer treatments because they were mostly derived from clinical trials. In Korea, up to 50% of BC patients are premenopausal women, it is not clear how age at diagnosis affect the progression and outcomes of the disease considering all known prognostic factors including TNM stage, ER, PR, and HER2 status. We aim to evaluate the impact of young age on recurrence and mortality after surgery among Korean women with BC.
Methods: This is a retrospective cohort study conducted using the data from BC registry from 2000 to 2016 at Samsung Medical Cancer, Seoul, Korea. Patients who received curative BC surgery and who had histologically-confirmed invasive BC between 2000 to 2011 were included in the study. Patients who second primary cancer or double primary cancer were excluded. Information local, regional, or distant recurrence and death until May 2016 was collected using electronic medical records and National Health Statistics. Cumulative incidence rates of distant recurrence and morality at 3-years, 5-years and 10-years were calculated using a competing-risk model. Cox proportional hazards analysis were conducted with 3 different models to take into account for potential confounding factors including age, body mass index (BMI), stage and subtype at breast cancer diagnosis, chemotherapy, radiotherapy and hormone therapy.
Results:There were 7360 BC patients with curative BC surgery between 2000 and 2011, and the average follow up duration was 75.4 months. The mean age at diagnosis was 48.4 years old (Standard deviation (SD)=±10), and 6.2% (n=459) was diagnosed younger than 35. Of total, 13.3% were stage III BC and 73.4% of patients had hormone receptor positive BC. The cumulative incidence (95%CI) of recurrence at 3, 5, and 10 years was 4.4% (3.9-4.9), 7.5% (6.8-8.2), and 14.8% (12.9-16.7) respectively. The incidence of mortality at 3, 5, and 10 years was 1.8% (1.5-2.1), 3.8% (3.3-4.3), and 10.2% (9.1-11.5) respectively. Patients who were diagnosed BC under 35 years of age had 2.14 (95% confidence interval (CI):1.74-3.10) and 1.62 (95% CI:1.02-2.56) times higher risk of distant recurrence and mortality compared to patients whose age at diagnosis were between 50 to 60 after adjusting all well-known prognostic factors including stage, subtype, and BMI at diagnosis, chemotherapy, radiotherapy and hormone therapy.
Conclusions: Young age at diagnosis (<35) was the most significant predictor on BC recurrence and mortality independently from BC stage and subtype. Further study is warranted to explain biologic background for the differences in outcomes in young women with BC.
Citation Format: Kim J-Y, Cho J, Kim H, Kang D, Jung HA, Lee S-H, Bae S, Yu JH, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im Y-H, Guallar E, Park YH. Impact of young age on recurrence and mortality after surgery in breast cancer: 15 years active surveillance [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P6-09-50.
Collapse
|
69
|
Haungs A, Apel W, Arteaga-Velázquez J, Bekk K, Bertaina M, Blümer J, Bozdog H, Brancus I, Cantoni E, Chiavassa A, Cossavella F, Daumiller K, Souza VD, Pierro FD, Doll P, Engel R, Fuhrmann D, Gherghel-Lascu A, Gils H, Glasstetter R, Grupen C, Heck D, Hörandel J, Huege T, Kampert KH, Kang D, Klages H, Link K, Łuczak P, Mathes H, Mayer H, Milke J, Mitrica B, Morello C, Oehlschläger J, Ostapchenko S, Pierog T, Rebel H, Roth M, Schieler H, Schoo S, Schröder F, Sima O, Toma G, Trinchero G, Ulrich H, Weindl A, Wochele J, Zabierowski J. KASCADE-Grande: Composition studies in the view of the post-LHC hadronic interaction models. EPJ WEB OF CONFERENCES 2017. [DOI: 10.1051/epjconf/201714513001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
70
|
Jang I, Lee SY, Hwangbo S, Kang D, Lee H, Kim HI, Moon B, Oh HB. TEMPO-Assisted Free Radical-Initiated Peptide Sequencing Mass Spectrometry (FRIPS MS) in Q-TOF and Orbitrap Mass Spectrometers: Single-Step Peptide Backbone Dissociations in Positive Ion Mode. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 2017; 28:154-163. [PMID: 27686973 DOI: 10.1007/s13361-016-1508-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/19/2016] [Revised: 08/15/2016] [Accepted: 09/13/2016] [Indexed: 06/06/2023]
Abstract
The present study demonstrates that one-step peptide backbone fragmentations can be achieved using the TEMPO [2-(2,2,6,6-tetramethyl piperidine-1-oxyl)]-assisted free radical-initiated peptide sequencing (FRIPS) mass spectrometry in a hybrid quadrupole time-of-flight (Q-TOF) mass spectrometer and a Q-Exactive Orbitrap instrument in positive ion mode, in contrast to two-step peptide fragmentation in an ion-trap mass spectrometer (reference Anal. Chem. 85, 7044-7051 (30)). In the hybrid Q-TOF and Q-Exactive instruments, higher collisional energies can be applied to the target peptides, compared with the low collisional energies applied by the ion-trap instrument. The higher energy deposition and the additional multiple collisions in the collision cell in both instruments appear to result in one-step peptide backbone dissociations in positive ion mode. This new finding clearly demonstrates that the TEMPO-assisted FRIPS approach is a very useful tool in peptide mass spectrometry research. Graphical Abstract ᅟ.
Collapse
|
71
|
Chung W, Lee K, Jung Y, Kim Y, Park J, Sheen S, Lee J, Kang D, Park K. Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis. Int J Tuberc Lung Dis 2016; 19:1476-84. [PMID: 26614189 DOI: 10.5588/ijtld.15.0325] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
SETTING Tertiary care academic medical centre. OBJECTIVE To evaluate the clinical utility of CXC chemokine receptor 3 (CXCR3) ligands in the diagnosis and monitoring of tuberculosis (TB). DESIGN Presumptive TB patients (active TB, 256; non-TB disease, 52) and 201 healthy controls were enrolled. The serum levels of interferon-gamma (IFN-γ) and CXCR3 ligands (CXCL9, a monokine induced by IFN-γ [MIG] and CXCL11, an IFN-inducible T-cell α chemoattractant [I-TAC]) were measured using enzyme-linked immunosorbent assay. An IFN-γ release assay (IGRA) was also performed. Serial samplings were performed in 19 TB patients at baseline and at 1, 2, 3, 6 and 12 months after treatment initiation. RESULTS All marker levels were higher in TB patients than in controls and non-TB patients. The area under the curve (AUC) for differentiating between all TB patients and controls was 0.96 (95%CI 0.94-0.98) for CXCL9, 0.84 (95%CI 0.80-0.87) for CXCL11 and 0.61 (95%CI 0.57-0.66) for IFN-γ. CXCL9 levels afforded particularly high discriminatory power between TB patients and IGRA-positive controls (AUC = 0.95, 95%CI 0.92-0.97). The levels of CXCR3 ligands decreased significantly during follow-up, and these changes were correlated with treatment response. CONCLUSION CXCR3 ligands CXCL9 and CXCL11 may be useful surrogate markers for the diagnosis and follow-up of TB.
Collapse
|
72
|
Cheng YSL, Jordan L, Chen HS, Kang D, Oxford L, Plemons J, Parks H, Rees T. Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers. J Periodontal Res 2016; 52:428-437. [PMID: 27549383 DOI: 10.1111/jre.12407] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/24/2016] [Indexed: 02/03/2023]
Abstract
BACKGROUND AND OBJECTIVE More than 100 salivary constituents have been found to show levels significantly different in patients with oral squamous cell carcinoma (OSCC) from those found in healthy controls, and therefore have been suggested to be potential salivary biomarkers for OSCC detection. However, many of these potential OSCC salivary biomarkers are also involved in chronic inflammation, and whether the levels of these biomarkers could be affected by the presence of chronic periodontitis was not known. The objective of this pilot study was therefore to measure the levels of seven previously reported potential OSCC salivary mRNA biomarkers in patients with chronic periodontitis and compare them to levels found in patients with OSCC and healthy controls. The seven salivary mRNAs were interleukin (IL)-8, IL-1β, dual specificity phosphatase 1, H3 histone family 3A, ornithine decarboxylase antizyme 1, S100 calcium-binding protein P (S100P) and spermidine/spermine N1-acetyltransferase 1. MATERIAL AND METHODS Unstimulated whole saliva samples were collected from a total of 105 human subjects from the following four study groups: OSCC; CPNS (chronic periodontitis, moderate to severe degree, non-smokers); CPS (chronic periodontitis, moderate to severe degree, smokers); and healthy controls. Levels of each mRNA in patient groups (OSCC or chronic periodontitis) relative to the healthy controls were determined by a pre-amplification reverse transcription-quantitative polymerase chain reaction approach with nested gene-specific primers. Results were recorded and analyzed by the Bio-Rad CFX96 Real-Time System. Mean fold changes between each pair of patient vs. control groups were analyzed by the Mann-Whitney U-test with Bonferroni corrections. RESULTS Only S100P showed significantly higher levels in patients with OSCC compared to both patients with CPNS (p = 0.003) and CPS (p = 0.007). The difference in S100P levels between patients with OSCC and healthy controls was also marginally significant (p = 0.009). There was no significant difference in the levels of salivary IL-8, IL-1β and dual specificity phosphatase 1 mRNAs between patients with OSCC and patients with CPNS (p = 0.510, 0.058 and 0.078, respectively); no significant difference in levels of salivary ornithine decarboxylase antizyme 1 and spermine N1-acetyltransferase mRNAs between patients with OSCC and patients with CPS (p = 0.318 and 0.764, respectively); and no significant difference in levels of the H3 histone family 3A mRNA between patients with OSCC and either CPS (p = 0.449) or healthy controls (p = 0.107). CONCLUSIONS Salivary S100P mRNA could be a reliable biomarker for OSCC detection, regardless of the presence of chronic periodontitis. The presence of chronic periodontitis could significantly affect the levels of the other six mRNAs, and negatively influence reliability for using them as biomarkers for oral cancer detection.
Collapse
|
73
|
Lee JK, Kang D, Choi EK, Kong S, Lee SK, Lee JE, Han W, Park YH, Ahn JS, Im YH, Noh DY, Nam SJ, Cho J. Abstract P1-10-31: Impact of increased physical activities after diagnosis on fatigue and overall pain during cancer treatment: A prospective cohort study. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p1-10-31] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
Existing evidence strongly suggests that exercise is not only safe but also feasible during cancer treatment. Physical activity is recommended for improving multiple post-treatment adverse effects on bone health, muscle strength, and other quality-of-life measures. Yet, limited evidence exists regarding effect of increased physical activity after diagnosis on symptoms management of breast cancer patients.
Methods
A total of 422 patients were recruited from July 2010 to July 2011 at two cancer hospitals in Seoul, Korea. Physical activity in sports (PAS) was assessed using Minnesota Leisure Time Physical Activity Questionnaire before and 2 weeks, 3-, 6-, 12-, 24- and 36-months after diagnosis. Physical symptoms including fatigue, pain, arm symptom, and insomnia were measured using EORTC-C30 and BR23. Growth mixture models were used to identify trajectory classes of physical activity patterns. Multivariate analysis was used to find impact of PAS on symptom management using SAS.
Results
Three distinct PAS groups were identified according to 3-year change patterns: moderate to moderate (MM): 40.8%, none to moderate (NM): 31.1% and moderate to high (MH): 28.1%. The LM and MH group increased PAS from diagnosis but it began to decrease from 1 year after diagnosis. Compared to the MM, the NM and MH reported significantly lower level of fatigue (MM:40.7, NM:32.2, MH:33.7), pain(MM:28.0, NM:25.6, MH:20.6), systemic therapy side effects (MM:26.9, NM:22.6, MH:21.8), and breast symptoms (MM:25.4, NM:21.7, MH:20.2) during active treatment (6 months after diagnosis).
Change patterns of quality of life according to trajectory groups At diagnosis2 weeks3 months6 months12 months24 months36 monthsFatigueMM31.3±1.930.2±1.935.3±2.0140.7±2.1137.8±2.1138.5±2.1141.0±2.21NM30.2±1.928.2±1.931.9±2.132.2±2.2233.6±2.135.6±2.2137.8±2.31MH28.8±2.327.4±2.233.0±2.433.7±2.51233.9±2.4136.2±2.5137.1±2.51PainMM15.1±1.531.3±1.9123.2±2.0128.0±2.0123.5±2.0122.0±2.0121.2±1.91NM15.4±1.532.4±2.023.3±2.0125.6±2.122.7±2.021.1±2.123.8±2.01MH17.2±1.828.4±2.3121.2±2.320.6±2.4219.7±2.321.1±2.318.6±2.2Systemic therapy side effectsMM16.8±1.114.3±1.2133.2±1.7126.9±1.5125.4±1.5126.2±1.6128.6±1.71NM15.0±1.114.5±1.235.2±1.7122.6±1.61222.0±1.6124.5±1.7127.7±1.81MH15.6±1.412.9±1.4134.4±2.0121.8±1.81221.8±1.7122.1±1.9124.7±2.01Breast symptomsMM13.8±1.226.4±1.6120.8±1.5125.4±1.6123.6±1.6119.2±1.7119.6±1.71NM13.0±1.224.7±1.6119.6±1.5121.7±1.61222.3±1.7119.9±1.8119.1±1.81MH16.0±1.424.1±1.8119.4±1.820.2±1.81217.8±1.8217.4±2.014.0±1.92*adjusted with age, stage, and radiotherapy 1 p<0.05 (differences from baseline within group), 2 p<0.05 (differences from MM group within time)
Conclusion
The results of the study confirmed that increased physical activity after diagnosis, even with patients who did not exercise at all before diagnosis, helps to control fatigue, pain, systemic side effects, and breast symptoms during treatment. It is necessary to find ways to promote physical activity after diagnosis and help patients to stay active during treatment.
Citation Format: Lee JK, Kang D, Choi E-K, Kong S, Lee S-K, Lee JE, Han W, Park YH, Ahn JS, Im YH, Noh D-Y, Nam S-J, Cho J. Impact of increased physical activities after diagnosis on fatigue and overall pain during cancer treatment: A prospective cohort study. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P1-10-31.
Collapse
|
74
|
Oh JE, Kim BC, Chang DH, Kwon M, Lee SY, Kang D, Kim JY, Hwang I, Yu JW, Nakae S, Lee HK. Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa. Proc Natl Acad Sci U S A 2016; 113:E762-71. [PMID: 26811463 PMCID: PMC4760794 DOI: 10.1073/pnas.1518589113] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Commensal microbiota are well known to play an important role in antiviral immunity by providing immune inductive signals; however, the consequence of dysbiosis on antiviral immunity remains unclear. We demonstrate that dysbiosis caused by oral antibiotic treatment directly impairs antiviral immunity following viral infection of the vaginal mucosa. Antibiotic-treated mice succumbed to mucosal herpes simplex virus type 2 infection more rapidly than water-fed mice, and also showed delayed viral clearance at the site of infection. However, innate immune responses, including type I IFN and proinflammatory cytokine production at infection sites, as well as induction of virus-specific CD4 and CD8 T-cell responses in draining lymph nodes, were not impaired in antibiotic-treated mice. By screening the factors controlling antiviral immunity, we found that IL-33, an alarmin released in response to tissue damage, was secreted from vaginal epithelium after the depletion of commensal microbiota. This cytokine suppresses local antiviral immunity by blocking the migration of effector T cells to the vaginal tissue, thereby inhibiting the production of IFN-γ, a critical cytokine for antiviral defense, at local infection sites. These findings provide insight into the mechanisms of homeostasis maintained by commensal bacteria, and reveal a deleterious consequence of dysbiosis in antiviral immune defense.
Collapse
|
75
|
Zheng Y, Zhang R, Kang D, Zhu W. Atrophoderma of Pasini and Pierini in zosteriform distribution. GIORN ITAL DERMAT V 2015; 150:753-755. [PMID: 26513045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|